AbbVie announces positive Phase 3 results for Upadacitinib in Alopecia Areata
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Based on the CRL, the STARGLO data do not provide sufficient evidence to support the proposed second-line DLBCL indication in the US patient population
European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Subscribe To Our Newsletter & Stay Updated